Repligen
RGEN
#2039
Rank
$9.33 B
Marketcap
$165.76
Share price
-0.46%
Change (1 day)
11.18%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : $2.92 Billion USD

According to Repligen 's latest financial reports the company's total assets are $2.92 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$2.82 B-0.05%
2023-12-31$2.83 B11.83%
2022-12-31$2.53 B7.35%
2021-12-31$2.35 B23.94%
2020-12-31$1.90 B35.91%
2019-12-31$1.40 B80.75%
2018-12-31$0.77 B4.18%
2017-12-31$0.74 B157.35%
2016-12-31$0.28 B97.56%
2015-12-31$0.14 B13.99%
2014-12-31$0.12 B8.13%
2013-12-31$0.11 B22.3%
2012-12-31$97.01 M
2011-03-31$72.29 M1.22%
2010-03-31$71.41 M-3.17%
2009-03-31$73.75 M7.14%
2008-03-31$68.83 M136.76%
2007-03-31$29.07 M1.67%
2006-03-31$28.59 M3.59%
2005-03-31$27.6 M-6.78%
2004-03-31$29.61 M10.53%
2003-03-31$26.79 M-7.96%
2002-03-31$29.11 M-9.45%
2001-03-31$32.14 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novavax
NVAX
$1.17 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$7.61 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$4.26 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$128.24 B 4,286.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$103.02 B 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$96.88 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.73 B 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$2.52 B-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$88.64 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$7.51 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA